Tranexamic Acid Articles
Bayer temporarily stops Trasylol marketing
21 November 2007
New Trasylol warnings after BART study deaths
5 November 2007
Bayer's Trasylol linked to CABG mortality risk
12 February 2007
Icatibant yields fast symptom improvement
23 October 2006
FDA public advisory on Bayer
9 October 2006
Positive results for icatibant in HAE trials
2 October 2006
Jerini sees progress in Icatibant HAE study
7 August 2006
Israel's Omrixplanning IPO in USA
15 September 2000
Dutch Government Reimbursement Blacklist Rises To 35
9 December 1996
Showing 1-10 of 10 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
